BICDL2
gene geneOn this page
Summary
BICDL2 (BICD family like cargo adaptor 2, HGNC:33584) is a protein-coding gene on chromosome 16p13.3, encoding BICD family-like cargo adapter 2 (A1A5D9).
Predicted to enable small GTPase binding activity. Predicted to be involved in Golgi to secretory granule transport and vesicle transport along microtubule. Predicted to be located in cytoplasm.
Source: NCBI Gene 146439 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 24 total — 2 pathogenic
- MANE Select transcript:
NM_001369667
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:33584 |
| Approved symbol | BICDL2 |
| Name | BICD family like cargo adaptor 2 |
| Location | 16p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000162069 |
| Ensembl biotype | protein_coding |
| OMIM | 617003 |
| Entrez | 146439 |
Gene structure
Transcript identifiers
Ensembl transcripts: 15 — 13 protein_coding, 2 retained_intron
ENST00000389347, ENST00000572240, ENST00000572449, ENST00000573514, ENST00000576826, ENST00000642419, ENST00000873753, ENST00000873754, ENST00000873755, ENST00000873756, ENST00000873757, ENST00000873758, ENST00000915135, ENST00000957824, ENST00000957825
RefSeq mRNA: 2 — MANE Select: NM_001369667
NM_001103175, NM_001369667
CCDS: CCDS45393
Canonical transcript exons
ENST00000572449 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001505609 | 3029545 | 3029739 |
| ENSE00003490279 | 3030935 | 3031150 |
| ENSE00003547680 | 3030696 | 3030812 |
| ENSE00003553190 | 3028700 | 3028830 |
| ENSE00003568461 | 3029280 | 3029429 |
| ENSE00003572109 | 3035215 | 3035526 |
| ENSE00003633887 | 3030449 | 3030595 |
| ENSE00003688891 | 3028348 | 3028468 |
| ENSE00003888875 | 3036894 | 3036944 |
| ENSE00003894474 | 3027682 | 3028273 |
Expression profiles
Bgee: expression breadth ubiquitous, 180 present calls, max score 98.52.
FANTOM5 (CAGE): breadth broad, TPM avg 0.9435 / max 54.2742, expressed in 337 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 155993 | 0.5929 | 250 |
| 155990 | 0.1899 | 95 |
| 155991 | 0.1308 | 54 |
| 155992 | 0.0298 | 23 |
Top tissues by expression
239 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| pancreatic ductal cell | CL:0002079 | 98.52 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 98.52 | gold quality |
| body of pancreas | UBERON:0001150 | 97.97 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 96.20 | gold quality |
| esophagus mucosa | UBERON:0002469 | 96.16 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 93.81 | gold quality |
| minor salivary gland | UBERON:0001830 | 93.66 | gold quality |
| skin of abdomen | UBERON:0001416 | 93.25 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 93.11 | gold quality |
| skin of leg | UBERON:0001511 | 92.20 | gold quality |
| mouth mucosa | UBERON:0003729 | 92.10 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 91.12 | gold quality |
| right uterine tube | UBERON:0001302 | 90.23 | gold quality |
| zone of skin | UBERON:0000014 | 89.22 | gold quality |
| ileal mucosa | UBERON:0000331 | 86.28 | gold quality |
| pancreas | UBERON:0001264 | 85.52 | gold quality |
| upper arm skin | UBERON:0004263 | 85.37 | silver quality |
| buccal mucosa cell | CL:0002336 | 85.35 | gold quality |
| transverse colon | UBERON:0001157 | 85.32 | gold quality |
| vagina | UBERON:0000996 | 84.28 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 84.23 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 83.97 | gold quality |
| parotid gland | UBERON:0001831 | 83.64 | gold quality |
| body of stomach | UBERON:0001161 | 82.70 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 80.46 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 80.28 | gold quality |
| prostate gland | UBERON:0002367 | 80.18 | gold quality |
| oral cavity | UBERON:0000167 | 80.01 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 79.46 | gold quality |
| stomach | UBERON:0000945 | 79.32 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-114 | yes | 56.11 |
| E-ANND-3 | yes | 9.43 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
8 targeting BICDL2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6077 | 99.99 | 68.04 | 2299 |
| HSA-MIR-6079 | 99.84 | 68.54 | 1170 |
| HSA-MIR-7-5P | 99.67 | 70.53 | 1809 |
| HSA-MIR-4758-3P | 99.12 | 63.96 | 869 |
| HSA-MIR-1225-3P | 97.29 | 64.60 | 876 |
| HSA-MIR-1913 | 97.07 | 66.20 | 1417 |
| HSA-MIR-1233-3P | 96.81 | 65.44 | 573 |
| HSA-MIR-6769A-3P | 94.91 | 61.36 | 412 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | bicdl2 | ENSDARG00000052427 |
| mus_musculus | Bicdl2 | ENSMUSG00000043782 |
| rattus_norvegicus | Bicdl2 | ENSRNOG00000003457 |
| drosophila_melanogaster | CG32137 | FBGN0052137 |
Paralogs (2): SPDL1 (ENSG00000040275), BICDL1 (ENSG00000135127)
Protein
Protein identifiers
BICD family-like cargo adapter 2 — A1A5D9 (reviewed: A1A5D9)
Alternative names: Bicaudal D-related protein 2, Coiled-coil domain-containing protein 64B
All UniProt accessions (2): A0A2R8Y2X6, A1A5D9
UniProt curated annotations — full annotation on UniProt →
Subunit / interactions. Interacts with RAB13.
Similarity. Belongs to the BICDR family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| A1A5D9-1 | 1 | yes |
| A1A5D9-2 | 2 |
RefSeq proteins (2): NP_001096645, NP_001356596* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR051149 | Spindly/BICDR_Dynein_Adapter | Family |
UniProt features (13 total): region of interest 4, compositionally biased region 3, sequence variant 2, coiled-coil region 2, chain 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A1A5D9-F1 | 80.99 | 0.63 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 52 (showing top):
GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_DN, GOBP_VESICLE_LOCALIZATION, GOBP_ORGANELLE_TRANSPORT_ALONG_MICROTUBULE, GOMF_GTPASE_BINDING, GOBP_VESICLE_CYTOSKELETAL_TRAFFICKING, GOBP_ORGANELLE_LOCALIZATION, CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP, LIU_LIVER_CANCER, DODD_NASOPHARYNGEAL_CARCINOMA_DN, MIKKELSEN_MEF_ICP_WITH_H3K27ME3, MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3, DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN, GOBP_INTRACELLULAR_TRANSPORT, GOBP_ESTABLISHMENT_OF_ORGANELLE_LOCALIZATION, GOBP_MICROTUBULE_BASED_TRANSPORT
GO Biological Process (2): vesicle transport along microtubule (GO:0047496), Golgi to secretory granule transport (GO:0055107)
GO Molecular Function (2): small GTPase binding (GO:0031267), protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| organelle transport along microtubule | 1 |
| vesicle cytoskeletal trafficking | 1 |
| intercellular transport | 1 |
| intracellular transport | 1 |
| GTPase binding | 1 |
| binding | 1 |
Protein interactions and networks
STRING
456 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| BICDL2 | BICD2 | Q8TD16 | 622 |
| BICDL2 | BICD1 | Q96G01 | 603 |
| BICDL2 | CCDC78 | A2IDD5 | 589 |
| BICDL2 | RAB13 | P51153 | 560 |
| BICDL2 | HOOK2 | Q96ED9 | 544 |
| BICDL2 | C20orf204 | A0A1B0GTL2 | 543 |
| BICDL2 | HOOK3 | Q86VS8 | 540 |
| BICDL2 | HOOK1 | Q9UJC3 | 501 |
| BICDL2 | RAB11FIP3 | O75154 | 500 |
| BICDL2 | FLYWCH2 | Q96CP2 | 487 |
| BICDL2 | CRACR2A | Q9BSW2 | 466 |
| BICDL2 | RASEF | Q8IZ41 | 460 |
| BICDL2 | HCFC1R1 | Q9NWW0 | 456 |
| BICDL2 | NINL | Q9Y2I6 | 448 |
| BICDL2 | TMEM235 | A6NFC5 | 432 |
IntAct
34 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| BICDL2 | KLC3 | psi-mi:“MI:0915”(physical association) | 0.670 |
| KLC3 | BICDL2 | psi-mi:“MI:0915”(physical association) | 0.670 |
| BICDL2 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| BICDL2 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| BICDL2 | API5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BICDL2 | RPL9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BICDL2 | KLC3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BICDL2 | TSGA10IP | psi-mi:“MI:0915”(physical association) | 0.560 |
| BICDL2 | PKP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BICDL2 | CDK17 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BICDL2 | psi-mi:“MI:0915”(physical association) | 0.370 | |
| BICDL2 | S | psi-mi:“MI:0915”(physical association) | 0.370 |
| BICDL2 | CFTR | psi-mi:“MI:0915”(physical association) | 0.370 |
| CFTR | BICDL2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| SYNC | BICDL2 | psi-mi:“MI:0914”(association) | 0.350 |
| CARD9 | BICDL2 | psi-mi:“MI:0914”(association) | 0.350 |
| API5 | BICDL2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| RPL9 | BICDL2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| KLC3 | BICDL2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| PKP1 | BICDL2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TSGA10IP | BICDL2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CDK17 | BICDL2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (14): KLC3 (Two-hybrid), CCDC64B (Two-hybrid), CCDC64B (Two-hybrid), CCDC64B (Two-hybrid), RPL9 (Two-hybrid), API5 (Two-hybrid), TSGA10IP (Two-hybrid), CCDC64B (Affinity Capture-MS), CCDC64B (Affinity Capture-MS), CCDC64B (Two-hybrid), CCDC64B (Two-hybrid), CCDC64B (Two-hybrid), CCDC64B (PCA), CCDC64B (Affinity Capture-MS)
ESM2 similar proteins: A0A140LIT1, A0A1B0GVG4, A0JNH6, A1A5D9, A6NC98, A6NGB0, A6NJZ7, A6NNM3, F6XLV1, O15049, O54887, P0C7N4, P58660, P60531, Q0D2H9, Q0P5D1, Q2KJ21, Q2TAC2, Q3LUD3, Q3T1I3, Q3TMW1, Q3V0F0, Q4QRL3, Q5JTB6, Q5RD60, Q66HR5, Q6NSJ2, Q6PHN1, Q6QZQ4, Q80VM7, Q8BP01, Q8C7U1, Q8CB62, Q8CGU1, Q8CHW5, Q8K2I2, Q8N137, Q8N283, Q8N6Y0, Q8R370
Diamond homologs: A1A5D9, Q0V9T6, Q6DIX6, Q6GLX3, Q8CHW5, Q8SWR2, A0JNT9, P0CF95, Q6ZP65, A0JMK8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
24 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 2 |
| Likely pathogenic | 0 |
| Uncertain significance | 7 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (2)
| Variant ID | HGVS | Classification |
|---|---|---|
| 253470 | GRCh37/hg19 16p13.3(chr16:2867891-3942436)x3 | Pathogenic |
| 2684774 | GRCh37/hg19 16p13.3(chr16:2606711-3935836)x3 | Pathogenic |
SpliceAI
2011 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:3028344:TCA:T | donor_loss | 1.0000 |
| 16:3028345:CACC:C | donor_loss | 1.0000 |
| 16:3028464:GGGCC:G | acceptor_gain | 1.0000 |
| 16:3028466:GCC:G | acceptor_gain | 1.0000 |
| 16:3028467:CC:C | acceptor_gain | 1.0000 |
| 16:3028467:CCC:C | acceptor_gain | 1.0000 |
| 16:3028468:CC:C | acceptor_gain | 1.0000 |
| 16:3028468:CCTAG:C | acceptor_loss | 1.0000 |
| 16:3028469:C:CC | acceptor_gain | 1.0000 |
| 16:3028469:CTAGG:C | acceptor_loss | 1.0000 |
| 16:3028470:T:G | acceptor_loss | 1.0000 |
| 16:3028474:C:CT | acceptor_gain | 1.0000 |
| 16:3028475:G:T | acceptor_gain | 1.0000 |
| 16:3028478:C:CT | acceptor_gain | 1.0000 |
| 16:3028694:GCTTA:G | donor_loss | 1.0000 |
| 16:3028695:CTTA:C | donor_loss | 1.0000 |
| 16:3028696:TTACT:T | donor_loss | 1.0000 |
| 16:3028697:TACTT:T | donor_loss | 1.0000 |
| 16:3028698:A:AC | donor_gain | 1.0000 |
| 16:3028698:ACT:A | donor_loss | 1.0000 |
| 16:3028699:C:CT | donor_gain | 1.0000 |
| 16:3028699:CT:C | donor_gain | 1.0000 |
| 16:3028699:CTT:C | donor_gain | 1.0000 |
| 16:3028699:CTTG:C | donor_gain | 1.0000 |
| 16:3028699:CTTGT:C | donor_gain | 1.0000 |
| 16:3028700:TTGTT:T | donor_gain | 1.0000 |
| 16:3028701:TGTTC:T | donor_gain | 1.0000 |
| 16:3028757:T:TA | donor_gain | 1.0000 |
| 16:3028826:GAGAT:G | acceptor_gain | 1.0000 |
| 16:3028827:AGAT:A | acceptor_gain | 1.0000 |
AlphaMissense
3197 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 16:3028353:A:G | W452R | 0.996 |
| 16:3028353:A:T | W452R | 0.996 |
| 16:3028351:C:A | W452C | 0.994 |
| 16:3028351:C:G | W452C | 0.994 |
| 16:3028361:A:G | L449P | 0.994 |
| 16:3028403:A:G | L435P | 0.992 |
| 16:3028356:C:G | A451P | 0.989 |
| 16:3028373:A:G | L445P | 0.987 |
| 16:3035294:C:T | G68D | 0.987 |
| 16:3035304:C:G | A65P | 0.987 |
| 16:3028349:T:G | Q453P | 0.984 |
| 16:3035295:C:G | G68R | 0.982 |
| 16:3035285:A:G | L71P | 0.981 |
| 16:3035315:A:G | L61P | 0.981 |
| 16:3028269:T:A | D455V | 0.980 |
| 16:3035294:C:A | G68V | 0.979 |
| 16:3028352:C:G | W452S | 0.978 |
| 16:3028269:T:G | D455A | 0.977 |
| 16:3028254:A:T | I460N | 0.976 |
| 16:3030812:C:G | A167P | 0.972 |
| 16:3030954:A:G | L160P | 0.972 |
| 16:3035297:A:G | L67P | 0.972 |
| 16:3035306:G:T | A64D | 0.972 |
| 16:3028381:C:A | K442N | 0.971 |
| 16:3028381:C:G | K442N | 0.971 |
| 16:3028395:C:G | A438P | 0.970 |
| 16:3028270:C:G | D455H | 0.969 |
| 16:3028377:C:G | A444P | 0.967 |
| 16:3028268:G:C | D455E | 0.966 |
| 16:3028268:G:T | D455E | 0.966 |
dbSNP variants (sampled 300 via entrez): RS1000024355 (16:3036078 C>T), RS1000028770 (16:3032511 C>T), RS1000308899 (16:3036969 C>T), RS1000447187 (16:3032401 C>A,G,T), RS1000525687 (16:3036757 GCCGGCGCCCCCGGTTCC>G), RS1000613828 (16:3028751 G>A,C), RS1000614794 (16:3037081 C>T), RS1000733136 (16:3033425 G>A), RS1000785412 (16:3033753 C>A), RS1001137490 (16:3037767 G>C), RS1001188656 (16:3032124 G>A,T), RS1001291884 (16:3032779 T>C,G), RS1001420158 (16:3037505 G>A), RS1001728763 (16:3027815 G>C,T), RS1001777650 (16:3028063 G>A)
Disease associations
OMIM: gene MIM:617003 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
27 total (human), top 27 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | increases expression, increases methylation, affects cotreatment | 3 |
| sodium arsenite | decreases expression, increases expression | 2 |
| Tobacco Smoke Pollution | increases expression, decreases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| sotorasib | affects cotreatment, increases expression | 1 |
| aminomethylphosphonic acid (AMPA) | decreases expression | 1 |
| pirinixic acid | affects binding, decreases expression, increases activity | 1 |
| ethyl-p-hydroxybenzoate | increases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| fipronil | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression | 1 |
| dorsomorphin | affects cotreatment, increases expression | 1 |
| licochalcone B | increases expression | 1 |
| jinfukang | decreases expression, affects cotreatment | 1 |
| trametinib | affects cotreatment, increases expression | 1 |
| NVP-BKM120 | affects cotreatment, increases expression | 1 |
| Air Pollutants | affects expression, increases abundance | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cisplatin | affects cotreatment, decreases expression | 1 |
| Estradiol | affects cotreatment, decreases expression | 1 |
| Melphalan | increases expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Smoke | decreases expression | 1 |
| 2,4-Dichlorophenoxyacetic Acid | decreases expression | 1 |
| Cadmium Chloride | increases expression | 1 |
| Particulate Matter | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.